Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2012
12/20/2012WO2011117378A3 Compositions comprising brimonidine for the treatment of erythema
12/20/2012WO2011102724A3 Disinfectant composition and its use in dental treatment
12/20/2012US20120323273 High strength suture with absorbable core and suture anchor combination
12/20/2012US20120323258 Compositions and kits for the removal of irritating compounds from bodily surfaces
12/20/2012US20120323200 Cooling composition and absorbent article comprising the same
12/20/2012US20120323163 Methods of using dual-effect liposome in therapy
12/20/2012US20120323093 Article and Method for Applying a Coupling Agent for a Non-Invasive Optical Probe
12/20/2012US20120322894 Direct Compression Polymer Tablet Core
12/20/2012US20120322880 Pharmaceutical Formulations of Modafinil
12/20/2012US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
12/20/2012US20120322805 Pharmaceutical compositions of semi-ordered drugs and polymers
12/20/2012US20120322782 Veterinary compositions
12/20/2012US20120322734 Pharmaceutical Compositions Including Low Dosages of Desmopressin
12/20/2012US20120322720 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
12/20/2012US20120322156 Membrane fusion proteins derived from reovirus
12/20/2012US20120321719 Sustained Delivery of Therapeutic Agents to an Eye Compartment
12/20/2012US20120321718 Method of Treating Lactose Intolerance Using Genetically Engineered Bacteria
12/20/2012US20120321717 Devices and pharmaceutical compositions for enhancing dosing efficiency
12/20/2012US20120321716 Technology for preventing abuse of solid dosage forms
12/20/2012US20120321715 Micelles for the solubilization of gossypol
12/20/2012US20120321714 Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof
12/20/2012US20120321713 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
12/20/2012US20120321712 Pharmaceutical Composition
12/20/2012US20120321711 Direct compression polymer tablet core
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
12/20/2012US20120321709 Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof
12/20/2012US20120321708 Sustained-release formulations of topiramate
12/20/2012US20120321707 Drug delivery system and method of manufacturing thereof
12/20/2012US20120321706 Novel gastroretentive dosage forms of poorly soluble drugs
12/20/2012US20120321705 Lineage Restricted Glial Precursors from the Central Nervous System
12/20/2012US20120321704 Compound sea Cucumber Product, Preparation Method, and Dosage Forms Thereof
12/20/2012US20120321703 Capsule for oral pet medicine
12/20/2012US20120321702 Pharmaceutical composition of lansoprazole
12/20/2012US20120321700 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
12/20/2012US20120321699 Method of inducing the production of protective anti-hiv-1 antibodies
12/20/2012US20120321698 Inhalable pharmaceutical compositions
12/20/2012US20120321697 Bpb-based cargo delivery system
12/20/2012US20120321696 Accelerating Thrombus Resolution Through Augmentation of p53 Activity
12/20/2012US20120321695 Use of PVP-Iodine Liposomes for Treatment of Herpes
12/20/2012US20120321694 Compositions and uses
12/20/2012US20120321693 Prg4 treatment for interstitial cystitis
12/20/2012US20120321692 Methods and Dressings for Sealing Internal Injuries
12/20/2012US20120321690 Adhesive patch
12/20/2012US20120321687 Compositions and methods for using and identifying antimicrobial agents
12/20/2012US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water
12/20/2012US20120321683 Liposome-Encapsulated Bicelles and Use Thereof in Diluted Systems
12/20/2012US20120321678 Intra-articularly supplementation method for treating joint diseases and injuries
12/20/2012US20120321677 Coated solid preparation
12/20/2012US20120321676 Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof
12/20/2012US20120321675 Methods of inhibiting cataracts and presbyopia
12/20/2012US20120321674 Technology for Preventing Abuse of Solid Dosage Forms
12/20/2012US20120321673 Transdermal drug delivery system and method of using the same
12/20/2012US20120321672 Method of treating attention deficit hyperactivity disorder
12/20/2012US20120321671 Method for reducing heat loss in neonatal mammalian subjects by transplanting brown adipocytes or precursors thereof
12/20/2012US20120321670 Formulations of nano-carriers and methods of preparing the same
12/20/2012US20120321669 Antigenic compositions
12/20/2012US20120321616 Stabilized liquid anti-rsv antibody formulations
12/20/2012US20120321574 Anhydrous topical skin preparations
12/20/2012US20120321566 Inhibition of biofilm formation by 1,2,3,4,6-penta-o-galloyl-d-glucopyranose
12/20/2012US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
12/20/2012US20120321554 Plexin d1 as a target for tumor diagnosis and therapy
12/20/2012US20120318262 Pyrvinium Wound Treatment Methods and Devices
12/20/2012DE102011105369A1 Stabile, wässrige Protein-Lösung oder Protein-Dispersion, Verfahren zur Herstellung der stabilen, wässrigen Lösung oder Dispersion und Verfahren zur Herstellung von Form- oder Flächengebilden, Imprägnierungen oder Beschichtungen aus der stabilen, wässrigen Protein-Lösung oder Protein-Dispersion sowie deren Verwendung Stable, aqueous protein solution or protein dispersion, process for producing the stable aqueous solution or dispersion, and process for producing molding or sheet materials, coatings or impregnations from the stable aqueous protein solution or protein dispersion and the use thereof
12/20/2012CA2839689A1 Coating composition suitable for pharmaceutical or nutraceutical dosage forms
12/20/2012CA2839538A1 High capacity diketopiperazine microparticles and methods
12/20/2012CA2839525A1 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
12/20/2012CA2839494A1 Coating composition suitable for pharmaceutical or nutraceutical dosage forms
12/20/2012CA2839408A1 Aromatic-cationic peptides and uses of same
12/20/2012CA2839301A1 Nuclear receptor modulators and their use for the treatment and prevention of cancer
12/20/2012CA2839270A1 Inhalable pharmaceutical compositions
12/20/2012CA2839200A1 Medical tissue-marker and manufacturing method for same
12/20/2012CA2839063A1 Activatable nanoprobes for intracellular drug delivery
12/20/2012CA2838326A1 Multi-layer capsule and manufacture method thereof
12/20/2012CA2833676A1 A sustained-release composition containing peptides as active ingredient
12/19/2012EP2535347A1 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
12/19/2012EP2535326A1 Novel lipidomimetic compounds and uses thereof
12/19/2012EP2535047A1 Nutritional composition, food supplement comprising said nutritional composition and kit comprising said food supplement
12/19/2012EP2535045A1 Pharmaceutical composition of lansoprazole
12/19/2012EP2535044A1 Enterically coated cysteamine, cystamine and derivatives thereof
12/19/2012EP2535042A1 Oral sustained-release composition comprising a macrolide
12/19/2012EP2535041A1 Interpenetrating networks, and related methods and composition
12/19/2012EP2534200A1 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
12/19/2012EP2534187A1 Active substance-releasing wound dressing
12/19/2012EP2534157A1 Prasugrel in micronized, crystalline form and pharmaceutical composition thereof
12/19/2012EP2534054A1 Process for providing a filled canister for an inhaler
12/19/2012EP2533814A2 Delivery of immunoglobulin variable domains and constructs thereof
12/19/2012EP2533800A2 Liquid formulation of follicle stimulating hormone
12/19/2012EP2533779A2 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase
12/19/2012EP2533777A1 Pharmaceutical compositions comprising fluticasone, tiotropium and sodium cromoglycate
12/19/2012EP2533776A1 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation
12/19/2012EP2533773A2 Topical dermal delivery device for nitric oxide delivery
12/19/2012EP2533772A2 Methods and compositions for wound healing
12/19/2012EP2533771A2 Transdermal therapeutic system for the administration of peptides
12/19/2012EP2533770A1 Enteric coating compositions and methods of making and using the same
12/19/2012EP2533769A1 Method and system for optimizing film production and minimizing film scrap
12/19/2012EP2533768A1 Methods of normalizing measured drug concentrations and testing for non-compliance with a drug treatment regimen
12/19/2012EP2533767A1 Pharmaceutical compositions comprising a combination of metformin and sitagliptin
12/19/2012EP2533766A2 Pharmaceutical mini-tablets for sustained release of flecainide acetate
12/19/2012EP2533765A2 Pharmaceutical compositions comprising formoterol and mometasone
12/19/2012EP2533764A1 Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 2991